Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 3
1953 3
1954 4
1955 11
1956 2
1957 2
1958 2
1959 3
1960 2
1961 1
1962 2
1963 6
1964 8
1965 4
1966 12
1967 9
1968 6
1969 17
1970 17
1971 16
1972 8
1973 20
1974 28
1975 34
1976 29
1977 23
1978 24
1979 29
1980 24
1981 30
1982 38
1983 28
1984 29
1985 25
1986 27
1987 37
1988 36
1989 42
1990 33
1991 16
1992 9
1993 9
1994 6
1995 8
1996 8
1997 8
1998 7
1999 8
2000 6
2001 3
2002 5
2003 10
2004 3
2005 4
2006 8
2007 13
2008 3
2009 2
2010 4
2011 6
2012 6
2013 4
2014 3
2015 5
2016 2
2017 2
2018 4
2019 3
2020 7
2021 2
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

856 results

Results by year

Filters applied: . Clear all
Page 1
Levorphanol versus methadone use: safety considerations.
Haider A, Reddy A. Haider A, et al. Ann Palliat Med. 2020 Mar;9(2):579-585. doi: 10.21037/apm.2020.02.01. Epub 2020 Feb 25. Ann Palliat Med. 2020. PMID: 32156130 Free article. Review.
Levorphanol has no impact on QTc prolongation and considerably less drug-drug interactions as compared to methadone. ...The objective of this article is to review and compare the safety considerations for methadone and levorphanol use....
Levorphanol has no impact on QTc prolongation and considerably less drug-drug interactions as compared to methadone. ...The objective …
Levorphanol: the forgotten opioid.
Prommer E. Prommer E. Support Care Cancer. 2007 Mar;15(3):259-64. doi: 10.1007/s00520-006-0146-2. Epub 2006 Oct 13. Support Care Cancer. 2007. PMID: 17039381 Review.
Levorphanol is also an N-methyl-D-aspartate (NMDA) receptor antagonist. ...Levorphanol can be given orally, intravenously, and subcutaneously. ...
Levorphanol is also an N-methyl-D-aspartate (NMDA) receptor antagonist. ...Levorphanol can be given orally, intravenously, and …
Levorphanol use: past, present and future.
Gudin J, Fudin J, Nalamachu S. Gudin J, et al. Postgrad Med. 2016 Jan;128(1):46-53. doi: 10.1080/00325481.2016.1128308. Epub 2015 Dec 27. Postgrad Med. 2016. PMID: 26635068 Review.
Levorphanol is a potent opioid analgesic that was first approved for use in the United States in 1953. Levorphanol is approved for use in moderate to severe pain where an opioid analgesic is appropriate. ...
Levorphanol is a potent opioid analgesic that was first approved for use in the United States in 1953. Levorphanol is approved …
Identifying Levorphanol Ingestion Using Urine Biomarkers in Health Care Patients.
Watson AR, Roberts A. Watson AR, et al. Pain Physician. 2018 Mar;21(2):E167-E171. Pain Physician. 2018. PMID: 29565959 Free article.
RESULTS: Nineteen urine samples with levorphanol listed as prescribed had median levorphanol/dextrorphan and 3-hydroxymorphinan concentrations of 1,881 ng/mL and 141 ng/mL, respectively. ...Therefore, the potential exists for patients prescribed levorphanol t …
RESULTS: Nineteen urine samples with levorphanol listed as prescribed had median levorphanol/dextrorphan and 3-hydroxymorphina …
Is levorphanol a better option than methadone?
Pham TC, Fudin J, Raffa RB. Pham TC, et al. Pain Med. 2015 Sep;16(9):1673-9. doi: 10.1111/pme.12795. Epub 2015 Aug 26. Pain Med. 2015. PMID: 26307179 Review.
OBJECTIVE: We review the basic and clinical pharmacology of methadone and suggest that levorphanol should receive attention as a possible alternative. CONCLUSION: Unlike methadone, levorphanol is a more potent NMDA antagonist, possesses a higher affinity for DOR and …
OBJECTIVE: We review the basic and clinical pharmacology of methadone and suggest that levorphanol should receive attention as a poss …
Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study.
Reddy A, Haider A, Arthur J, Hui D, Dalal S, Dev R, Tanco K, Amaram-Davila J, Hernandez F, Chavez P, De Moraes AR, Wu J, Nguyen K, Subbiah I, Epner D, Shelal Z, Guay MOD, Mallipeddi T, Bruera E. Reddy A, et al. J Pain Symptom Manage. 2023 Jun;65(6):e683-e690. doi: 10.1016/j.jpainsymman.2023.01.013. Epub 2023 Jan 28. J Pain Symptom Manage. 2023. PMID: 36720398 Clinical Trial.
The ORR to levorphanol was calculated using net-MEDD (MEDD before OR minus the MEDD of the breakthrough opioid used along with levorphanol after OR). ...Levorphanol was associated with improved pain and symptom control and was well- tolerated....
The ORR to levorphanol was calculated using net-MEDD (MEDD before OR minus the MEDD of the breakthrough opioid used along with lev …
Levorphanol revisited.
Prommer EE. Prommer EE. J Palliat Med. 2007 Dec;10(6):1228-30. doi: 10.1089/jpm.2007.0133. J Palliat Med. 2007. PMID: 18095794 No abstract available.
Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic.
Le Rouzic V, Narayan A, Hunkle A, Marrone GF, Lu Z, Majumdar S, Xu J, Pan YX, Pasternak GW. Le Rouzic V, et al. Anesth Analg. 2019 Feb;128(2):365-373. doi: 10.1213/ANE.0000000000003360. Anesth Analg. 2019. PMID: 29649035 Free PMC article.
BACKGROUND: Levorphanol is a potent analgesic that has been used for decades. Most commonly used for acute and cancer pain, it also is effective against neuropathic pain. ...Compared to morphine, levorphanol had less respiratory depression at equianalgesic doses. .. …
BACKGROUND: Levorphanol is a potent analgesic that has been used for decades. Most commonly used for acute and cancer pain, it also i …
Opioids and chronic neuropathic pain.
Foley KM. Foley KM. N Engl J Med. 2003 Mar 27;348(13):1279-81. doi: 10.1056/NEJMe030014. N Engl J Med. 2003. PMID: 12660393 No abstract available.
856 results